InvestorsHub Logo
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

Re: BioChica post# 124431

Tuesday, 05/28/2013 11:39:46 AM

Tuesday, May 28, 2013 11:39:46 AM

Post# of 345971
The ASCO abstract, which stated that a patient discontinued with Bavi, but still remains in the trial
receiving paclitaxel, was written months ago. I do not believe they would "replace" her, it is all part of
the trial to see what safety issues arise, including "infusion related reactions". So when it was announced
on April 29th that the trial had completed enrollment with 14 patients I believe that patient was probably
still enrolled in the trial and receiving paclitaxel.

"By all means let's be open-minded, but not so open-minded that our brains drop out." - Richard Dawkins

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News